Zobrazeno 1 - 10
of 36
pro vyhledávání: '"S. Asavakarn"'
Autor:
S. Limsrichamrern, S. Asavakarn, P. Kositamongkol, V. Sanphasitvong, Yongyut Sirivatanauksorn, Wethit Dumronggittigule, Prawej Mahawithitwong, Chutwichai Tovikkai, Ananya Pongpaibul
Publikováno v:
Transplantation Proceedings. 49:1114-1117
Background Liver transplantation (LT) is one of the standard treatments for hepatocellular carcinoma (HCC), and the outcomes have become better after introduction of strict patient selection, such as the Milan criteria. However, several expanded crit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4c38eb754b6339f384cde03913152c
https://doi.org/10.1016/j.transproceed.2017.03.047
https://doi.org/10.1016/j.transproceed.2017.03.047
Autor:
S. Asavakarn, S. Limsrichamrern, Yongyut Sirivatanauksorn, A. Ruenrom, Prawej Mahawithitwong, R. Promraj, P. Kositamongkol, Chutwichai Tovikkai, Wethit Dumronggittigule
Publikováno v:
Transplantation Proceedings. 48:1202-1207
Drug adherence is one of the most important factors determining graft and patient survivals after liver transplantation. A systematic pharmaceutical educational approach has been implemented to improve adherence in immunosuppressive drugs therapy at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6dc72fc23862be906ff858254032e41
https://doi.org/10.1016/j.transproceed.2015.12.100
https://doi.org/10.1016/j.transproceed.2015.12.100
Autor:
A. Ruenrom, R. Promraj, S. Asavakarn, Prawej Mahawithitwong, S. Limsrichamrern, Yongyut Sirivatanauksorn, Chutwichai Tovikkai, P. Kositamongkol, Wethit Dumronggittigule
Publikováno v:
Transplantation Proceedings. 48:1198-1201
Background Immunosuppressive medication is one of the pivotal factors in the outcome of liver transplant patients. Nonadherence to immunosuppressive therapy is a common problem after transplantation and affects graft and patient survival. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ed42d2fc6fe3936cce6cec864f690a
https://doi.org/10.1016/j.transproceed.2015.12.097
https://doi.org/10.1016/j.transproceed.2015.12.097
Publikováno v:
HPB. 23:S618
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90ec8276fb59cf2fe9c2656c6ecccc31
https://doi.org/10.1016/j.hpb.2021.06.317
https://doi.org/10.1016/j.hpb.2021.06.317
Autor:
S. Asavakarn
Publikováno v:
HPB. 23:S437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccbbd351f52d3e852aa64c9e0a63492a
https://doi.org/10.1016/j.hpb.2020.11.1131
https://doi.org/10.1016/j.hpb.2020.11.1131
Publikováno v:
HPB. 23:S362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1c196c5c5e5d4b1353b7a4ae0a894e0
https://doi.org/10.1016/j.hpb.2020.11.925
https://doi.org/10.1016/j.hpb.2020.11.925
Autor:
Wethit Dumronggittigule, Yongyut Sirivatanauksorn, Chutwichai Tovikkai, C. Chanapul, S. Limsrichamrern, Prawej Mahawithitwong, S. Asavakarn, P. Kositamongkol
Publikováno v:
Transplantation Proceedings. 48:1176-1178
Background Tacrolimus is the most widely used immunosuppressive drug after liver transplantation. Whole blood tacrolimus level is used for drug monitoring. Because of strong uptake by erythrocytes (95% to 98%), hematocrit level is an important factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f2e6dfbf47ad872fc96bbc83bfb6cf
https://doi.org/10.1016/j.transproceed.2015.12.096
https://doi.org/10.1016/j.transproceed.2015.12.096
Autor:
Ananya Pongpaibul, Yongyut Sirivatanauksorn, S. Limsrichamrern, P. Mahawithitwong, S. Asavakarn, N. Kongkaewpaisan, C. Tovikkai, P. Kositamongkol
Publikováno v:
Transplantation Proceedings. 46:778-781
Y. Sirivatanauksorn, N. Kongkaewpaisan, A. Pongpaibul, S. Limsrichamrern, P. Mahawithitwong,P. Kositamongkol, C. Tovikkai, and S. AsavakarnABSTRACTBackground. Orthotopic liver transplantation (OLT) is an effective treatment for pa-tients who have end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e1038a8378c50db54a18368cdd5b43
https://doi.org/10.1016/j.transproceed.2014.02.026
https://doi.org/10.1016/j.transproceed.2014.02.026
Autor:
Prawej Mahawithitwong, S. Limsrichamrern, Wethit Dumronggittigule, Yongyut Sirivatanauksorn, P. Kositamongkol, C. Iramaneerat, S. Asavakarn, Chutwichai Tovikkai, Teera Kolladarungkri
Publikováno v:
Transplantation Proceedings. 44:532-538
Background Orthotopic liver transplantation (OLT) is the treatment of choice for end-stage disease. It offers a chance to return to an active and prolonged life. Recently, more attention is being paid to the health-related quality of life (HRQoL) of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0911a5048983f5e88e1d87e82022bd05
https://doi.org/10.1016/j.transproceed.2011.12.056
https://doi.org/10.1016/j.transproceed.2011.12.056
Autor:
S., Limsrichamrern, C., Tovikkai, S., Bunyajetpong, Y., Sirivatanauksorn, P., Kositamongkol, P., Mahawithitwong, S., Asavakarn, W., Dumronggittigule
Publikováno v:
Journal of the Medical Association of Thailand; Feb2019, Vol. 102 Issue 2, p1-6, 6p